Table 4. Assessed fecal microbiota in healthy subjects at baseline and after four and eight weeks of daily treatment with B. infantis 35624 and after 2 weeks of post-supplementation follow-up.
| Microbiota | Study Visit | Treatment |
|---|---|---|
| |
|
B. infantis 35624 (log 10 ng DNA g−1) |
| |
|
Mean (SE) |
| Bifidobacterium spp |
Baseline |
4.12 (0.202) |
| |
Week 4 |
4.43 (0.092) |
| |
Week 8 |
4.37 (0.113) |
| |
Follow-up |
4.34 (0.111) |
| Lactobacillus group |
Baseline |
3.53 (0.092) |
| |
Week 4 |
3.50 (0.056) |
| |
Week 8 |
3.37 (0.076) |
| |
Follow-up |
3.25 (0.078) |
| Veillonella spp |
Baseline |
2.21 (0.167) |
| |
Week 4 |
2.42 (0.109) |
| |
Week 8 |
2.39 (0.099) |
| |
Follow-up |
2.36 (0.117) |
| Desulfovibrio gp |
Baseline |
2.89 (0.267) |
| |
Week 4 |
2.83 (0.096) |
| |
Week 8 |
2.83 (0.122) |
| |
Follow-up |
2.83 (0.141) |
| Ruminococcus productus-Clostridium coccoides |
Baseline |
2.53 (0.118) |
| |
Week 4 |
2.63 (0.056) |
| |
Week 8 |
2.55 (0.049) |
| |
Follow-up |
2.55 (0.063) |
| Clostridium coccoides-Eubacterium rectale gp |
Baseline |
5.58 (0.059) |
| |
Week 4 |
5.70 (0.042) |
| |
Week 8 |
5.64 (0.044) |
| |
Follow-up |
5.57 (0.049) |
| Bifidobacterium catenlatum gp |
Baseline |
1.29 (0.361) |
| |
Week 4 |
1.62 (0.084) |
| |
Week 8 |
1.69 (0.127) |
| Follow-up | 1.45 (0.158) |
Healthy subjects received B. infantis 35624 supplementation for eight weeks. No supplement was administered at baseline or during follow-up (weeks 9 and 10).